Trials / Completed
CompletedNCT05822518
Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the outcome of perioperative immune-nutrition with glutamine, arginine and fish oil in patients undergoing radical cystectomy as regards to enhancement of healing, increasing immunity and improving overall health status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Neo-mune powder (otsuka pharmaceutical) | * Preoperative: Neo-mune (otsuka pharmaceutical) powder 60 gm o.d. orally (contains glutamine, arginine and fish oil) for 3 days. * Postoperative: Neo-mune (otsuka pharmaceutical) powder 60 gm o.d. orally (contains glutamine, arginine and fish oil) for 2 weeks starting when the intestinal sounds are audible. |
| DRUG | Dipeptiven solution (Fresenius Kabi pharmaceutical) | Dipeptiven (Fresenius Kabi pharmaceutical) solution 50 mg o.d IV ( contains L-ananyl-L-glutamine dipeptide) post operatively for 5 days starting from the operation day. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2023-11-30
- Completion
- 2024-02-01
- First posted
- 2023-04-20
- Last updated
- 2024-03-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05822518. Inclusion in this directory is not an endorsement.